shank3 overexpression causes manic-like behaviour unique pharmacogenetic properties 
mutations shank3 large duplications region spanning shank3 cause spectrum neuropsychiatric disorders indicating proper shank3 dosage critical normal brain function however shank3 overexpression per se established cause human disorders 22q13 duplications involve several genes report shank3 transgenic mice modelling human shank3 duplication exhibit manic-like behaviour seizures consistent synaptic excitatory/inhibitory imbalance also identified two patients hyperkinetic disorders carrying smallest shank3-spanning duplications reported far findings indicate shank3 overexpression causes hyperkinetic neuropsychiatric disorder probe mechanism underlying phenotype generated shank3 vivo interactome found shank3 directly interacts arp2/ complex increase f-actin levels shank3 transgenic mice mood-stabilizing drug valproate lithium rescues manic-like behaviour shank3 transgenic mice raising possibility hyperkinetic disorder unique pharmacogenetic profile 
